Neuroprotective Mechanisms Mediated by CDK5 Inhibition
Gohar Mushtaq1, Nigel H Greig2, Firoz Anwar
1Department of Biochemistry, College of Science, King Abdulaziz University, Jeddah 21589, Saudi Arabia. gmushtaq2001@gmail.com.
Current Pharmaceutical Design
|November 26, 2015
Summary
Cyclin-dependent kinase 5 (CDK5) deregulation contributes to neurodegeneration via multiple pathways. Inhibiting CDK5 may offer neuroprotection against neuronal insults and diseases like Alzheimer's.
Area of Science:
- Neuroscience
- Molecular Biology
- Pharmacology
Background:
- Cyclin-dependent kinase 5 (CDK5) is crucial for neuronal structure and function.
- Deregulation of CDK5 is implicated in neurodegenerative diseases and stroke.
Purpose of the Study:
- To review the mechanisms linking CDK5 deregulation to neurodegeneration.
- To explore the potential of CDK5 inhibition for neuroprotection.
Main Methods:
- Literature review of studies on CDK5 in neurodegeneration.
- Analysis of pathways involving CDK5 overactivation and neurotoxicity.
Main Results:
- CDK5 deregulation contributes to neurodegeneration through tau hyperphosphorylation, cytoskeletal disruption, and excitotoxicity.
- Specific mechanisms include cyclin D1 upregulation, p25/CDK5 complex formation, and colchicine-induced apoptosis.
Conclusions:
- Understanding CDK5's role is key to developing targeted therapies.
- Selective CDK5 inhibitors could treat Alzheimer's, ALS, and stroke-related neuronal loss.
Related Concept Videos
02:34Inhibition of Cdk Activity
6.2K
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
6.2K
02:34Inhibition of CDK Activity
5.6K
5.6K
01:23Negative Regulator Molecules
38.9K
Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
38.9K
02:39Positive Regulator Molecules
7.1K
Mitotic cell division results in daughter cells that exactly resemble the parent cell. However, errors in the DNA replication or distribution of genetic material may lead to genetic mutations that may be passed down to every new cell formed from the resulting abnormal cell. Propagation of such mutant cells is restricted through checkpoint mechanisms present at different stages of the cell cycle. These checkpoints involve regulator molecules that either promote or demote cell cycle events.
7.1K
01:45Positive Regulator Molecules
137.1K
To consistently produce healthy cells, the cell cycle—the process that generates daughter cells—must be precisely regulated.
137.1K
02:15M-Cdk Drives Transition Into Mitosis
6.8K
Checkpoints throughout the cell cycle serve as safeguards and gatekeepers, allowing the cell cycle to progress in favorable conditions and slow or halt it in problematic ones. This regulation is known as the cell cycle control system.
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
6.8K